Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160035/S061

EXCOR Pediatric VAD

Berlin Heart, Inc. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONP160035/S061

What did the FDA decide?

The FDA record P160035/S061 describes a 30-Day Notice supplement filed for the EXCOR Pediatric Ventricular Assist Device, submitted by Berlin Heart, Inc. The supplement reason is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier. Its statement identifies the changed item as manufacturing facility modifications at the Berlin Heart GmbH facility in Berlin, Germany, for production of the device.

The identifier links this supplement to the original PMA P160035, but the decision does not constitute a new approval of the whole system. Beyond the facility location and the manufacturing-change label, the record does not specify which production steps, equipment or processes were modified, nor does it present independent evidence of safety or clinical effectiveness; the reported purpose of the notice remains distinct from such proof.

FDA approval order statement

manufacturing facility modifications at the Berlin Heart GmbH facility in Berlin, Germany for the production of the EXCOR Pediatric Ventricular Assist Device
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160035/S061
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
OK30
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P160035. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160035 · Original PMA

    EXCOR Pediatric Ventricular Assist Device

  2. P160035/S058 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  3. P160035/S061 received

    Application receipt date recorded by FDA.

  4. P160035/S057 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  5. P160035/S060 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  6. P160035/S061 · FDA decision

    30-Day Notice

  7. P160035/S054 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

Timeline entries are records held by MedtechLedger for P160035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160035

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA approvalJun 6, 2017FDA
Berlin Heart, Inc.PMA supplementSep 1, 2026FDA
Berlin Heart, Inc.PMA supplementOct 1, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
HeartMate II LVASP060040/S128
ABBOTT MEDICALPMA supplementOct 1, 2026FDA
HeartMate 3 LVASP160054/S135
ABBOTT MEDICALPMA supplementOct 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Berlin Heart, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9391 Grogan'S Mill Rd., Suite A-6, The Woodlands, TX, 77380

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records